Dubrajpur Medical Education & Research Institute Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 9 Year, 28 Days
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2019)
- Profit -5.55%
(FY 2019)
- Ebitda -7.79%
(FY 2019)
- Net Worth -288.55%
(FY 2019)
- Total Assets -46.19%
(FY 2019)
About Dubrajpur Medical Education & Research Institute
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mustak Khan, Sekh Najiruddin, and Islam Jafarul serve as directors at the Company.
- CIN/LLPIN
U74900WB2015PTC208804
- Company No.
208804
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Birbhum, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dubrajpur Medical Education & Research Institute?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mustak Khan  | Director | 14-Dec-2015 | Current |
| Sekh Najiruddin | Director | 14-Dec-2015 | Current |
| Islam Jafarul | Director | 14-Dec-2015 | Current |
Financial Performance of Dubrajpur Medical Education & Research Institute.
Dubrajpur Medical Education & Research Institute Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 5.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 288.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dubrajpur Medical Education & Research Institute?
Unlock access to Dubrajpur Medical Education & Research Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dubrajpur Medical Education & Research Institute?
Unlock and access historical data on people associated with Dubrajpur Medical Education & Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dubrajpur Medical Education & Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dubrajpur Medical Education & Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
